Found: 18
Select item for more details and to access through your institution.
Definition of the Immune Parameters Related to COVID-19 Severity.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.850846
- By:
- Publication type:
- Article
Renal function in HIV/ HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2017, v. 44, n. 2, p. 191, doi. 10.1111/1440-1681.12691
- By:
- Publication type:
- Article
Improving D-dimer testing appropriateness by controlling periodicity of retesting: prevention is better than cure.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2022, v. 60, n. 8, p. e175, doi. 10.1515/cclm-2022-0389
- By:
- Publication type:
- Article
SARS-CoV-2 serologic tests: do not forget the good laboratory practice.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Searching for a role of procalcitonin determination in COVID-19: a study on a selected cohort of hospitalized patients.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2021, v. 59, n. 1, p. 433, doi. 10.1515/cclm-2020-1361
- By:
- Publication type:
- Article
An unexpectedly prolonged severe hyperbilirubinemia in a patient with pre-existing hepatitis A: a role of genetic predisposition?
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2019, v. 57, n. 7, p. e145, doi. 10.1515/cclm-2018-0962
- By:
- Publication type:
- Article
Suppressing all test results in grossly hemolyzed samples: is this approach appropriate in every case?
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
Undetected Toxicity Risk in Pharmacogenetic Testing for Dihydropyrimidine Dehydrogenase.
- Published in:
- International Journal of Molecular Sciences, 2015, v. 16, n. 4, p. 8884, doi. 10.3390/ijms16048884
- By:
- Publication type:
- Article
Fluoropyrimidine-Associated Toxicity in Two Gastrointestinal Cancer Patients: Potential Role of Common DPYD Polymorphisms.
- Published in:
- Chemotherapy (0009-3157), 2017, v. 62, n. 5, p. 323, doi. 10.1159/000477333
- By:
- Publication type:
- Article
Clinical and genetic determinants of nevirapine plasma trough concentration.
- Published in:
- SAGE Open Medicine, 2018, v. 6, p. 1, doi. 10.1177/2050312118780861
- By:
- Publication type:
- Article
Pharmacogenetics-based optimisation of atazanavir treatment: potential role of new genetic predictors.
- Published in:
- Drug Metabolism & Personalized Therapy, 2017, v. 32, n. 2, p. 115, doi. 10.1515/dmpt-2017-0006
- By:
- Publication type:
- Article
Pharmacogenetic approach to losartan in Marfan patients: a starting point to improve dosing regimen?
- Published in:
- Drug Metabolism & Personalized Therapy, 2016, v. 31, n. 3, p. 157, doi. 10.1515/dmpt-2016-0006
- By:
- Publication type:
- Article
DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 80, n. 3, p. 581, doi. 10.1111/bcp.12631
- By:
- Publication type:
- Article
ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors.
- Published in:
- Pharmacology, 2015, v. 96, n. 3/4, p. 163, doi. 10.1159/000438486
- By:
- Publication type:
- Article
Seizures in Patients with Chronic Hepatitis C Treated with NS3/4A Protease Inhibitors: Does Pharmacological Interaction Play a Role?
- Published in:
- Pharmacology, 2014, v. 92, n. 5/6, p. 235, doi. 10.1159/000355836
- By:
- Publication type:
- Article
ABCB1 c.3435C>T polymorphism is associated with platinum toxicity: a preliminary study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 4, p. 1155, doi. 10.1093/jac/dku519
- By:
- Publication type:
- Article